Furthermore, in addition to the role of ACE2 and TMPRSS2 as an entry of the virus through the nasal tissue to the brain, several studies have linked their brain distribution to certain neurological effects of COVID-19 (Boldrini et al., 2021; Hernández et al., 2021; Kulkarni et al., 2022). This evidence concerns the gene ACE2 and COVID-19.